CleveMed Issued Another Patent in the area of Obstructive Sleep Apnea Diagnosis

Apr 13, 2017

CleveMed, Cleveland, OH – June 13, 2017 – CleveMed, a leading provider of home sleep apnea testing (HSAT) solutions was issued another patent (9,615,773) that relates to identifying the location of airway obstructions during sleep apnea events. The patent is entitled “Method and Device for Sleep Analysis and Therapy”.

“This patent expands our Intellectual Property portfolio in OSA diagnosis to include a form of airway imaging during apneic events. Such information about airway behavior during sleep apnea could be useful in optimizing surgical intervention options for patients”, said Hani Kayyali, CleveMed president.

Obstructive sleep apnea (OSA), the most prevalent form of sleep apnea, is a repeated interruption of normal breathing during sleep due to a collapse of the upper airway. It is estimated to impact as many people as asthma and diabetes; yet, up to 80 percent of the population with the disease remain undiagnosed and untreated. Moreover, OSA leads to serious health and economic consequences. Numerous studies link OSA to major chronic diseases such as stroke, heart failure, diabetes, obesity, hypertension and increased odds of serious car crash injuries. Such co-existing conditions can alter patient’s ability to benefit from sleep apnea therapy, and therefore could necessitate the re-evaluation of treatment.

CleveMed is a fast growing company with a wide range of sleep testing equipment, services, and cloud based technologies that allow sleep disorders to be monitored in the home, including Sapphire PSG™, SleepScout™, SleepView®, SleepViewSM Web-portal, and SleepView Direct. CleveMed’s goal is to expand the reach of sleep medicine with technologies that speed diagnosis for providers, reduce healthcare costs for payers, and improve patients’ experiences in the home. For more information, please visit (Follow us on twitter, youtube, LinkedIn, and facebook). SleepView is a registered trademark and a service mark, and Sapphire PSG and SleepScout are trademarks of Cleveland Medical Devices Inc. of Cleveland, OH.